Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2010

01-10-2010 | American Society of Breast Surgeons

Use of Breast MRI Surveillance in Women at High Risk for Breast Cancer: A Single-Institutional Experience

Authors: Leisha Elmore, BS, Julie A. Margenthaler, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2010

Login to get access

Abstract

Introduction

The study aim is to investigate indications for breast magnetic resonance imaging (MRI) screening for high-risk women and to determine outcomes, correlation with routine imaging, and adherence to current guidelines for use.

Methods

We identified 200 patients undergoing 275 breast MRIs for high-risk surveillance from 2005 to 2008. Data collected included patient characteristics, need for additional imaging and/or biopsy, correlation with routine imaging, and outcomes. Gail scores were calculated for patients without hereditary breast cancer syndromes or previous chest radiation. Descriptive statistics were utilized for data summary.

Results

Two hundred patients underwent 275 breast MRIs for high-risk surveillance (mean age 45 years, range 18–76 years). Indications included BRCA mutation (n = 21), history of chest radiation (n = 10), and perceived high risk (n = 169). The mean Gail score for the latter group was 25% (range 10–46%); 32 (16%) patients had Gail score <20%. Of 275 MRIs, 49 (18%) required additional imaging and 21 (8%) prompted biopsy. Of 21 biopsies, 4 were malignant; 2 were also visible on routine imaging performed concurrently with breast MRI. The false-positive rate for breast MRI screening in our cohort of high-risk patients was 23%.

Conclusion

The rate of cancer detection in high-risk patients undergoing breast MRI at our institution is similar to that of large, multicenter trials. Sixteen percent of patients undergoing breast MRI did not meet high-risk criteria. Because the need for additional imaging and biopsy remains high, further investigation is necessary to determine if this strategy is cost effective.
Literature
1.
go back to reference Ries L, Kosary C, Hankey B. SEER cancer statistics review, 1975–2000. USA National Cancer Institute 2003. Ries L, Kosary C, Hankey B. SEER cancer statistics review, 1975–2000. USA National Cancer Institute 2003.
2.
go back to reference Kriege M, Brekelmans C, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427–37.CrossRefPubMed Kriege M, Brekelmans C, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427–37.CrossRefPubMed
3.
go back to reference Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469–76.CrossRefPubMed Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469–76.CrossRefPubMed
4.
go back to reference Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer. 2005;103:1898–905.CrossRefPubMed Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer. 2005;103:1898–905.CrossRefPubMed
5.
go back to reference Stoutjesdijk MJ, Boetes C, Jager GJ, et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst. 2001;93:1095–102.CrossRefPubMed Stoutjesdijk MJ, Boetes C, Jager GJ, et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst. 2001;93:1095–102.CrossRefPubMed
6.
go back to reference Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, clinical breast examination. JAMA. 2004;292:1317–25.CrossRefPubMed Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, clinical breast examination. JAMA. 2004;292:1317–25.CrossRefPubMed
7.
go back to reference Kuhl CK, Schrading S, Wardelmann E, et al. Magnetic resonance imaging versus mammography for diagnosing ductal carcinoma in situ. J Clin Oncol. 2007;25:1504–10. Kuhl CK, Schrading S, Wardelmann E, et al. Magnetic resonance imaging versus mammography for diagnosing ductal carcinoma in situ. J Clin Oncol. 2007;25:1504–10.
8.
go back to reference Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370:485–92.CrossRefPubMed Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370:485–92.CrossRefPubMed
9.
go back to reference Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75–89.CrossRefPubMed Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75–89.CrossRefPubMed
10.
go back to reference Carney P, Miglioretti D, Yankaskas B. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168–75.PubMed Carney P, Miglioretti D, Yankaskas B. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168–75.PubMed
11.
go back to reference Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000;92:1081–7.CrossRefPubMed Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000;92:1081–7.CrossRefPubMed
12.
go back to reference Rosenberg RD, Hunt WC, Williamson MR, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183, 134 screening mammograms in Albuquerque, New Mexico. Radiology. 1998;209:511–8.PubMed Rosenberg RD, Hunt WC, Williamson MR, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183, 134 screening mammograms in Albuquerque, New Mexico. Radiology. 1998;209:511–8.PubMed
13.
go back to reference Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology. 1993;187:493–501.PubMed Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology. 1993;187:493–501.PubMed
14.
go back to reference Hrung JM, Sonnad SS, Schwartz JS, Langlotz CP. Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad Radiol. 1999;6:387–97.CrossRefPubMed Hrung JM, Sonnad SS, Schwartz JS, Langlotz CP. Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad Radiol. 1999;6:387–97.CrossRefPubMed
15.
go back to reference Peters NHGM, Rinkes IHMB, Zuithoff NPA, Mali WPTM, Moons KGM, Peeters PHM. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology. 2008;246:116–24.CrossRefPubMed Peters NHGM, Rinkes IHMB, Zuithoff NPA, Mali WPTM, Moons KGM, Peeters PHM. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology. 2008;246:116–24.CrossRefPubMed
16.
go back to reference Gail M, Brinton L, Byar D, Corle D, Green S, Schairer C. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–86.CrossRefPubMed Gail M, Brinton L, Byar D, Corle D, Green S, Schairer C. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–86.CrossRefPubMed
17.
go back to reference Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early onset breast cancer. Cancer. 1994;73:643–51.CrossRefPubMed Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early onset breast cancer. Cancer. 1994;73:643–51.CrossRefPubMed
18.
go back to reference Miki Y, Swenson J, Shattuck-Eidens S, et al. A strong candidate gene for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71.CrossRefPubMed Miki Y, Swenson J, Shattuck-Eidens S, et al. A strong candidate gene for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71.CrossRefPubMed
19.
go back to reference Euhus DM, Leitch AM, Huth JF, et al. Limitations of the Gail model in the specialized breast cancer risk assessment clinic. Breast J. 2002;8:23–27.CrossRefPubMed Euhus DM, Leitch AM, Huth JF, et al. Limitations of the Gail model in the specialized breast cancer risk assessment clinic. Breast J. 2002;8:23–27.CrossRefPubMed
20.
go back to reference Hoskins KF, Zwaagstra A, Ranz M. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer. 2006;107:1769–76.CrossRefPubMed Hoskins KF, Zwaagstra A, Ranz M. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer. 2006;107:1769–76.CrossRefPubMed
21.
go back to reference Taneja C, Edelsberg J, Weycker D, Guo A, Oster G, Weinreb J. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high risk women. J Am Coll Radiol. 2009;6:171.CrossRefPubMed Taneja C, Edelsberg J, Weycker D, Guo A, Oster G, Weinreb J. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high risk women. J Am Coll Radiol. 2009;6:171.CrossRefPubMed
Metadata
Title
Use of Breast MRI Surveillance in Women at High Risk for Breast Cancer: A Single-Institutional Experience
Authors
Leisha Elmore, BS
Julie A. Margenthaler, MD
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1236-4

Other articles of this Special Issue 3/2010

Annals of Surgical Oncology 3/2010 Go to the issue

American Society of Breast Surgeons

Regional Management of Breast Cancer